MMedication Read More Is it a surprise middle-class women are using Ozempic most?February 18, 2026 New research reveals a startling truth about the people paying thousands for weight-loss drugs: they’re mostly middle-aged, wealthy…
MMedication Read More Martin Lewis shares NHS ‘prescription season ticket’ that could save Brits £360February 18, 2026 Thousands of Brits have been overpaying for prescriptions (Picture: Getty Images) In Scotland and Wales, NHS prescriptions are…
MMedication Read More Prescription-strength co-codamol supplies limited until summer, Scottish Government confirmsFebruary 18, 2026 Prescription-strength co-codamol supplies are expected to remain limited until the summer, the Scottish Government has said. A UK-wide…
MMedication Read More Women and middle classes dominate weight loss jab take-up | UK NewsFebruary 18, 2026 Women and the middle classes are dominating take-up of weight loss jabs, research suggests. Almost 80% of private…
MMedication Read More Dr Reddy’s says Wegovy copycat to be priced competitively, with 50-60pc discounts feasibleFebruary 18, 2026 HYDERABAD, Feb 18 — Indian drugmaker Dr Reddy’s Laboratories hopes to launch a generic version of Novo Nordisk’s…
MMedication Read More More drugs should be over-the-counterFebruary 18, 2026 Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
MMedication Read More Clinton’s life could be cut short unless he pays thousands for PBS-listed medicationFebruary 18, 2026 After being diagnosed with a rare and aggressive form of thyroid cancer 10 years ago, father-of-three Clinton finally…
MMedication Read More Pharmacists urge national advisory line to manage medicines shortages – Australian Journal of PharmacyFebruary 18, 2026 Pharmacists urge national advisory line to manage medicines shortages Australian Journal of PharmacyCall for real-time shortages guide Pharmacy DailyCalls grow…
MMedication Read More Middle-class women aged 30-50 are main buyers of weight-loss drugsFebruary 18, 2026 Middle-class women in their thirties and forties make up the bulk of those taking weight-loss jabs, a study…
MMedication Read More FDA Approves FILKRIâ„¢ (filgrastim-laha), Accord BioPharma’s Biosimilar to NEUPOGEN® (filgrastim)February 18, 2026 In the news release, FDA Approves FILKRIâ„¢ (filgrastim-laha), Accord BioPharma’s Biosimilar to NEUPOGEN® (filgrastim), issued 17-Feb-2026 by Accord…
MMedication Read More I’m a longevity doctor — 3 peptides to help live longerFebruary 18, 2026 When the fountain of youth’s under construction, you may want to dip into peptides instead. Chances are you’ve…
MMedication Read More We’re reading about China’s GLP-1 drugs, a puzzling FDA rejectionFebruary 18, 2026 Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and rewarding…